Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Citrate for Hyperphosphatemia in CKD Patients on Hemodialysis
NCT04456803Phase 3Completed
- Sponsor
- Sinomune Pharmaceutical
- Start
- May 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric citrate in hyperphosphatemia, sponsored by Sinomune Pharmaceutical. Started May 2019; status: completed.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT04456803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04456803.